US (OH): "$1.5 million investment demonstrates confidence in our organic living soil cultivation"

KEY Investment Partners today announced a $1.5 million investment in FarmaceuticalRX, a vertically integrated cannabis operator in the State of Ohio. "The investment by KEY is a strong show of confidence for the Company's approach to cannabis cultivation, processing, and product development."

In addition to KEY's capital investment, KEY Founding Partner Pete Karabas will join FRX's Board of Directors alongside FRX Founder and CEO Rebecca Myers to assist the company with its strategic growth initiatives in 2022 and beyond.

"We've been very impressed with Rebecca and her team's ability to consistently deliver high-quality, organic cannabis products at a competitive price to medical cannabis patients across the State of Ohio. In the relatively near future, we expect the state to develop a robust recreational program and believe FRX will play a key role in making that program a success," Karabas said.

Using an organic cultivation method referred to as living soil cultivation, FarmaceuticalRX grows cannabis following traditional organic practices that closely mimics Mother Nature's optimal, natural conditions to produce premium organic craft medical cannabis products with every harvest. Plants are cultivated in living soil, and environmental conditions are obsessively monitored and controlled. These high standards enable the company to reliably replicate the unique genetic profile of each cultivar to exacting standards, creating consistently high cannabinoid and terpene levels with each harvest. The FarmaceuticalRX processing team then formulates products with a goal of allowing patients to achieve condition-specific relief, whether that be through live resin vape and concentrate products, solvent-less products, RSO, or edibles products. FarmaceuticalRX anticipates receiving final organic certification in Q4 of 2022.

"We are extremely gratified by the confidence KEY Investment Partners has demonstrated through its commitment to our future," said Rebecca Myers, Founder, and CEO of FarmaceuticalRX. "The addition of Pete Karabas to our board will be instrumental as we continue to grow our presence across the State of Ohio."

KEY Investment Partners has continued to deploy capital into the cannabis industry throughout several different verticals in 2022. Their investment in FRX is a reflection of KEY's confidence in the continued growth of the cannabis industry, even in the midst of challenging macroeconomic times.